Shareholder alert: weiss law investigates alimera sciences, inc.

New york, ny / accesswire / june 26, 2024 / weiss law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of alimera sciences, inc. ("alimera" or the "company") (nasdaq:alim), in connection with its acquisition by ani pharmaceuticals, inc. (nasdaq: anip). under the merger agreement, the company's shareholders will receive $5.50per share in cash at closing and one non-tradable contingent value right ("cvr") to receive up to $0.50 per share upon the achievement of certain net revenue targets in 2026 and 2027.
ALIM Ratings Summary
ALIM Quant Ranking